Washington University School of Medicine

Digital Commons@Becker
2020-Current year OA Pubs

Open Access Publications

9-6-2022

Multimodal single cell sequencing implicates chromatin
accessibility and genetic background in diabetic kidney disease
progression
Parker C Wilson
Washington University School of Medicine in St. Louis

Yoshiharu Muto
Washington University School of Medicine in St. Louis

Haojia Wu
Washington University School of Medicine in St. Louis

Anil Karihaloo
Novo Nordisk Research Center Seattle Inc

Sushrut S Waikar
Boston University

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/oa_4
Part of the Medicine and Health Sciences Commons

Recommended Citation
Wilson, Parker C; Muto, Yoshiharu; Wu, Haojia; Karihaloo, Anil; Waikar, Sushrut S; and Humphreys,
Benjamin D, "Multimodal single cell sequencing implicates chromatin accessibility and genetic
background in diabetic kidney disease progression." Nature Communications. 13, 1. 5253 (2022).
https://digitalcommons.wustl.edu/oa_4/354

This Open Access Publication is brought to you for free and open access by the Open Access Publications at
Digital Commons@Becker. It has been accepted for inclusion in 2020-Current year OA Pubs by an authorized
administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

Authors
Parker C Wilson, Yoshiharu Muto, Haojia Wu, Anil Karihaloo, Sushrut S Waikar, and Benjamin D Humphreys

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/oa_4/354

nature communications
Article

https://doi.org/10.1038/s41467-022-32972-z

Multimodal single cell sequencing implicates
chromatin accessibility and genetic background in diabetic kidney disease
progression
Received: 2 March 2022

1234567890():,;

1234567890():,;

Accepted: 25 August 2022

Check for updates

Parker C. Wilson
Sushrut S. Waikar

1,6

, Yoshiharu Muto 2,6, Haojia Wu
& Benjamin D. Humphreys 2,5

2

, Anil Karihaloo3,

4

The proximal tubule is a key regulator of kidney function and glucose metabolism. Diabetic kidney disease leads to proximal tubule injury and changes in
chromatin accessibility that modify the activity of transcription factors
involved in glucose metabolism and inﬂammation. Here we use single nucleus
RNA and ATAC sequencing to show that diabetic kidney disease leads to
reduced accessibility of glucocorticoid receptor binding sites and an injuryassociated expression signature in the proximal tubule. We hypothesize that
chromatin accessibility is regulated by genetic background and closelyintertwined with metabolic memory, which pre-programs the proximal tubule
to respond differently to external stimuli. Glucocorticoid excess has long been
known to increase risk for type 2 diabetes, which raises the possibility that
glucocorticoid receptor inhibition may mitigate the adverse metabolic effects
of diabetic kidney disease.

Diabetes is the leading cause of end-stage renal disease (ESRD) and a
signiﬁcant contributor to morbidity and mortality1. An estimated 40%
of patients with diabetes develop chronic kidney disease (CKD), which
manifests as worsening proteinuria and renal dysfunction2. Single cell
sequencing is a powerful technique that has advanced our understanding of kidney biology3. Multimodal integration of single nucleus
RNA (snRNA-seq) and assay for transposase-accessible chromatin
sequencing (snATAC-seq) provides insight into how transcription
factors and chromatin-chromatin interactions regulate expression of
nearby genes4.
Glucocorticoids and mineralocorticoids comprise a class of hormones called corticosteroids produced in the adrenal cortex. Cortisol
is the primary endogenous glucocorticoid that binds glucocorticoid
receptor (GR), which is expressed in proximal tubule, thick ascending

limb, endothelium, and podocytes3. Chronic exposure to endogenous
cortisol and long-term treatment with synthetic glucocorticoids has
been linked to type 2 diabetes and metabolic syndrome5,6. Single-cell
sequencing of human DKD has shown that the thick ascending limb
and distal nephron have a transcriptional signature consistent with
altered corticosteroid signaling7. GR also acts on the proximal tubule
where it increases expression of gluconeogenic genes to drive the
synthesis of glucose from non-carbohydrate substrates like lactate,
glutamine, and glycerol8,9. The kidney contributes approximately half
of circulating glucose during prolonged fasting and studies have
demonstrated that both glucose reabsorption and gluconeogenesis
are increased in type 2 diabetes8.
Genetic variation contributes to the risk of type 2 diabetes and
DKD progression as shown by genome wide association studies
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(GWAS)10–12. Many of the variants identiﬁed by GWAS are common
(MAF > 0.01) and explain a small proportion of heritability of type 2
diabetes and kidney disease12. GWAS have been used to investigate a
wide variety of kidney-function-related traits, however, one of the
difﬁculties with GWAS is assigning function to risk variants located in
non-coding regions13,14. Recent studies have shown that a signiﬁcant
proportion of GWAS variants for type 1 and type 2 diabetes are located
in cell-speciﬁc open chromatin regions15,16. The relationship between
gene expression and chromatin accessibility can be modeled using
allele-speciﬁc chromatin accessibility (ASCA)17–19. snATAC-seq can
measure ASCA by quantifying the ratio of ATAC peak fragments that
intersect heterozygous germline SNV. It can also predict CRE gene
targets within cis-coaccessibility networks (CCAN), which makes it a
compelling method for estimating the effect of SNV in open chromatin
regions18. These methods open the door to novel techniques for geneenhancer predictions and quantitation of single cell allele-speciﬁc
effects20.
We have performed snRNA-seq and snATAC-seq on kidney cortex
from patients with and without type 2 diabetes to identify cell-speciﬁc
differentially expressed genes and accessible chromatin regions
associated with diabetic kidney disease (DKD). We validated key ﬁndings from our multimodal analysis with cleavage under targets and
release using nuclease (CUT&RUN) and CRISPR interference (CRISPRi)
to directly measure transcription factor binding and modify chromatin
accessibility of cis-regulatory elements (CRE). Epigenetic regulation of
chromatin accessibility may contribute to long-term expression of
DKD-related genes in a process termed metabolic memory21. Our
analysis identiﬁed cell-speciﬁc changes in chromatin accessibility that
co-localize with transcription factor binding sites associated with
glucose metabolism and corticosteroid signaling in the diabetic
nephron.

number of ATAC peaks compared to less common cell types, which is
likely a function of increased power and sequencing depth (Supplementary Fig. 2). The aggregated dataset was analyzed in Signac following doublet removal with AMULET and batch effect correction with
Harmony20,23,24. A total of 68,458 cells passed quality control ﬁlters and
all major cell types in the kidney cortex were represented (Fig. 1A). Cell
types were identiﬁed based on increased chromatin accessibility
within gene body and promoter regions of lineage-speciﬁc markers
(Supplementary Fig. 3) and enrichment for cell-speciﬁc ATAC peaks
(Supplementary Dataset 2). The most abundant cell type was the
proximal convoluted tubule (PCT), which comprised approximately
one third of snATAC-seq cells, and DKD samples had a trend towards
greater number of inﬁltrating leukocytes (mean of 42 vs. 211, p = 0.10),
including B cells, T cells, and mononuclear cells. We previously
described an injured population of VCAM1 + proximal tubule cells
(PT_VCAM1) that increase in response to acute kidney injury, aging,
and CKD3. PT_VCAM1 can be distinguished from PCT by expression of
VCAM1 and HAVCR1 (KIM-1), which is a marker of kidney injury (Supplementary Fig. 3). There was a greater proportion of PT_VCAM1 in
DKD samples compared to control samples (mean proportion 0.12 vs.
0.03, Wilcoxon rank sum p = 0.004), however, this proportion varied
widely by donor (Supplementary Fig. 4). There was another closely
related cluster of cells that we designated PT_PROM1 (Fig. 1A). The
PT_PROM1 cluster was PROM1high VCAM1- in contrast to PT_VCAM1,
which was PROM1low VCAM1+ (Supplementary Fig. 3). We hypothesize
that the PT_PROM1 cluster represents a population of CD133 + VCAM1cells that we previously identiﬁed in control kidney, which raises the
possibility that there are multiple proximal tubule states related to
cellular injury or inﬂammation3.

Results

We compared DKD and control samples to identify 7358 cell-speciﬁc
differentially accessible chromatin regions (DAR) that met the adjusted p-value threshold (Supplementary Dataset 3, Benjamini Hochberg
padj < 0.05), including 1315 that also met an absolute log-fold-change
threshold of 0.1 (Fig. 1B). The majority of DAR showed decreased
accessibility rather than increased accessibility (923 vs. 392) and many
were located in a promoter region (Fig. 1B). In contrast, a minority of
DAR were intergenic (156/1315, 11%) located a median distance of 22 kb
from the nearest transcriptional start site (TSS). Approximately one
third of intergenic DAR (n = 59/156, 37%) and one fourth of intronic
DAR (n = 58/240, 24%) mapped to a FANTOM enhancer25. The proximal
convoluted tubule (PCT) had the greatest number of DAR (n = 422)
followed by the proximal straight tubule (PST), PT_VCAM1, and thick
ascending limb (Fig. 1C). Less abundant cell types like podocytes and
endothelial cells had few if any DAR, which likely reﬂects our limited
power to detect them. Among 1315 total DAR, 975 were unique because
a subset of DAR were shared between multiple cell types (Fig. 1C). DAR
present in multiple cell types included regions within or near ATP1B1
(Supplementary Fig. 5 and 6). ATP1B1 encodes a subunit of the sodium
potassium ATPase, suggesting that DAR in diabetes may elicit a conserved effect on ion transport across nephron segments.
We grouped DAR from the proximal convoluted tubule (PCT) and
proximal straight tubule (PST) and annotated them with the nearest
protein-coding gene to perform gene ontology enrichment. Genes
near proximal tubule DAR were enriched for pathways involved in
response to insulin, cellular response to peptides, response to hormone stimuli, and ion transport (Fig. 1D). Insulin resistance is a key
feature of DKD and we identiﬁed proximal tubule DAR with decreased
chromatin accessibility near multiple genes that regulate insulin signaling (Supplementary Dataset 3)26. There was a DAR in the second
intron of the insulin receptor (INSR) that showed decreased accessibility in the proximal tubule (Fig. 1E, Orange Arrow). This region was
predicted to regulate INSR expression via a CCAN (Fig. 1E, Green Arcs)

Patient demographics and clinical information
For snRNA-seq and snATAC-seq, a total of thirteen kidney cortex
samples were obtained from control patients (n = 6), and patients with
diabetic kidney disease (DKD, n = 7). Tissue samples were collected
following nephrectomy for renal mass (n = 10) or from deceased organ
donors (n = 3). Patients ranged in age from 50 to 78 years (median =
57 y) and included seven men and six women (Supplementary Dataset 1). Patients with type 2 diabetes had elevated hemoglobin A1c
(mean = 8.2 +/− 1.5%). The majority of patients with DKD were on
antihypertensive or ACE inhibitor therapy and two patients were on
insulin. Two patients with DKD had mild to moderate proteinuria as
measured by urine dipstick.

Renal histology of donor samples
Tissue sections were stained with H&E and examined by a renal
pathologist (P.W.) to evaluate histological features of DKD. Control
samples did not have signiﬁcant global glomerulosclerosis (<10%) or
interstitial ﬁbrosis and tubular atrophy (<10%). Patients with DKD had
predominantly mild (N = 3, <25%) or moderate (N = 3, 26–50%) global
glomerulosclerosis with a corresponding increase in interstitial ﬁbrosis
and tubular atrophy (Supplementary Fig. 1). Mean eGFR of DKD samples (66 +/− 25 ml/min/1.73 m2) and control samples (74 +/− 15 ml/min/
1.73 m2) was not statistically different (Students t-test, p = 0.49). DKD
samples showed nodular mesangial expansion, thickened glomerular
basement membranes and afferent arteriolar hyalinosis.

Single nucleus ATAC sequencing in type 2 diabetes
The snATAC-seq dataset included six control samples and seven with
DKD. snATAC-seq libraries were counted with cellranger-atac (10X
Genomics) and aggregated prior to cell-speciﬁc peak calling with
MACS220,22. We detected 437,311 accessible chromatin regions (‘ATAC
peaks’) across all cell types. More abundant cell types had a larger
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and was associated with decreased INSR expression in the corresponding snRNA-seq dataset (Fig. 1F). We did a pairwise comparison
between all control and DKD snATAC-seq samples to show that the
effect size and direction of this INSR DAR is largely reproducible across
donors (Supplementary Fig. 7). The loop of Henle is a key regulator of
sodium reabsorption where we identiﬁed two DAR in the promoter
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region of ATP1B1 (Supplementary Fig. 6). These DAR were present in
both the ascending thin limb (ATL) and thick ascending limb (TAL1,
TAL2) where they showed decreased chromatin accessibility.
Decreased chromatin accessibility was associated with decreased
ATP1B1 expression in the same cell types in the corresponding snRNAseq dataset. Together, these ﬁndings suggest that DKD is associated
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Fig. 1 | snATAC-seq of human DKD. A UMAP of snATAC-seq dataset. Six control
and seven DKD samples with 68,458 cells. PCT-proximal convoluted tubule, PSTproximal straight tubule, PT_VCAM1-VCAM1(+) proximal tubule, PT_PROM1PROM1(+) proximal tubule, PT_CD36-CD36(+) proximal tubule, PEC-parietal epithelial cells, ATL-ascending thin limb, TAL1-CLDN16(-) thick ascending limb, TAL2CLDN16(+) thick ascending limb, DCT1-early distal convoluted tubule, DCT2-late
distal convoluted tubule, PC-principal cells, ICA-type A intercalated cells, ICB-type B
intercalated cells, PODO-podocytes, ENDO-endothelial cells, FIB_VSMC_MC-ﬁbroblasts, vascular smooth muscle cells and mesangial cells, TCELL-T cells, BCELL-B
cells, MONO-mononuclear cells. B Effect size and location of DAR in DKD. Control
cell types were compared to DKD to identify cell-speciﬁc DAR (Source data are
provided in Supplementary Dataset 3). Signiﬁcance was evaluated with a
Bonferroni-adjusted Wilcoxon Rank Sum test. DAR with padj < 0.05 that met an
absolute log2-fold-change threshold of 0.1 (horizontal bars) were annotated relative to the nearest TSS. C DAR in DKD that are cell-speciﬁc or shared between cell
types. DAR that were shared between multiple cell types or unique to a cell type are

displayed. (Source data are provided in Supplementary Dataset 3). D Proximal
tubule DAR pathway enrichment. Cell-speciﬁc DAR from PCT and PST were annotated with the nearest protein-coding gene to perform gene ontology enrichment.
Fold-enrichment for all signiﬁcant GO biological processes is shown and the top 25
are highlighted (Source data are provided as a Source Data ﬁle). E Proximal tubulespeciﬁc DAR and ATAC peaks in the insulin receptor. snATAC-seq coverage plots
for DKD and control PCT are displayed. The orange arrow indicates a DAR in intron
2 that shows decreased accessibility in DKD (chr19:7196798-7198626, foldchange = 0.92, padj = 7.7 × 10−13). Differentially methylated regions (DMR) associated with end-stage kidney disease due to diabetes are shown as blue bars (see
Methods). Green arcs depict the nodes of a cis-coaccessibility network (CCAN).
Statistical signiﬁcance was evaluated using a Bonferroni-adjusted Wilcoxon Rank
Sum test. F Proximal tubule INSR expression by snRNA-seq. Control proximal
tubule was compared to DKD to identify DEGs. DKD proximal tubule showed
reduced INSR expression (fold-change = 0.78, padj = 1.2 × 10−27). Statistical signiﬁcance was evaluated using a Bonferroni-adjusted Wilcoxon Rank Sum test.

with changes in chromatin accessibility that regulate expression of
genes important for insulin signaling and sodium reabsorption.
We compared the proximal convoluted tubule (PCT) and
PT_VCAM1 to identify changes in chromatin accessibility associated
with the pro-inﬂammatory PT_VCAM1 cell state (Supplementary
Dataset 4). There were 4,498 DAR and the majority showed decreased
accessibility (N = 3055, 68%). Gene ontology analysis of nearby proteincoding genes showed enrichment for pathways involved in kidney
development, metabolism, amino acid transport, epithelial cell proliferation, response to glucocorticoids, and regulation of transforming
growth factor beta signaling. ATAC peaks with increased chromatin
accessibility in PT_VCAM1 were located near pro-inﬂammatory genes
like IL-6, CD40, and TGFB2 in addition to genes involved in proliferation
like EGFR and MYC.

signaling, and ion transport. For example, INSR showed decreased
expression in the proximal tubule (Fig. 1F), thick ascending limb, and
distal convoluted tubule (Supplementary Dataset 6). Additional
enzymes in the gluconeogenic pathway were also upregulated in the
diabetic proximal tubule (Fig. 2D). Together, these ﬁndings suggest
that the diabetic proximal tubule increases expression of genes that
promote both glucose reabsorption (SLC5A2) and glucose production
(PCK1, ALDOB, FBP1, G6PC). Comparison with the corresponding
snATAC-seq dataset showed multiple proximal tubule DAR near PCK1
(Fig. 2E, Orange Boxes), suggesting that changes in chromatin accessibility may lead to increased PCK1 expression. PCK1 DAR were located
both within and distal to its gene body where they interacted with the
promoter via a CCAN (Fig. 2E, Green Arcs). Similar relationships
between PCT DAR and CCAN were observed near ALDOB, FBP1, and
G6PC (Supplementary Figs. 9–11).
The diabetic thick ascending limb (TAL1) had 622 differentially
expressed genes compared to controls (padj < 0.05, |avg_log2FC| >
0.25). Differentially expressed genes in TAL1 were enriched for pathways involved in nitric oxide signaling, ATP biosynthesis, anion transport, and cellular response to cAMP, EGFR signaling, glucocorticoids,
hypoxia, and insulin. Similar to the diabetic proximal tubule, there was
decreased expression of INSR (fold-change = 0.76, padj = 1.5 × 10−17) and
increased expression of GR (NR3C1, fold-change = 1.26, padj = 4.7 ×
10−10). There was also decreased expression of HSD11B2 (foldchange = 0.71, padj = 5.3 × 10−33), which is the enzyme that catalyzes the
conversion of cortisol to the inactive metabolite cortisone to protect
nonselective activation of MR. In fact, decreased HSD11B2 expression
was observed in every cell type in the distal nephron (Supplementary
Dataset 6). These data support our hypothesis that the diabetic
nephron has increased GR signaling due to increased GR expression
and decreased activity of the enzyme responsible for metabolizing
cortisol.
We compared the proximal tubule and PT_VCAM1 to identify
differentially expressed genes associated with the PT_VCAM1 cell
state. There were 3842 differentially expressed genes (Supplementary Dataset 7) enriched for pathways involved in cell migration,
EGFR signaling, insulin receptor signaling, histone deacetylation,
regulation of glycolysis, and TGF-beta signaling. For example, INSR
expression was decreased in PT_VCAM1 relative to PT (foldchange = 0.67, padj = 4.1 × 10−53) and TGFBR2 was increased (foldchange = 1.34, padj = 5.4 × 10−34). These changes were accompanied
by a modest increase in GR expression (NR3C1, fold-change = 1.07,
padj = 2.0 × 10−10) and a marked reduction in FKBP5 (fold-change =
0.45, padj = 4.9 × 10−117).

Single nucleus RNA sequencing to detect differentially expressed genes in type 2 diabetes
A total of eleven snRNA-seq libraries were aggregated with cellranger
(10X Genomics) and analyzed with Seurat following doublet removal
with DoubletFinder and batch effect correction with Harmony4,23,27.
The snRNA-seq dataset included six control samples and ﬁve with DKD.
A total of 39,176 cells passed quality control ﬁlters and all major cell
types in the kidney cortex were represented (Fig. 2A), including the
PT_VCAM1 population3. snRNA-seq cell types largely expressed the
same lineage-speciﬁc markers that showed increased chromatin
accessibility in the snATAC-seq dataset (Supplementary Fig. 8) and
were enriched for cell-speciﬁc genes (Supplementary Dataset 5). There
was a greater proportion of PT_VCAM1 in DKD compared to controls
(mean proportion 0.06 vs. 0.02, Wilcoxon rank sum p = 0.03). We
compared individual cell types between control and DKD samples to
identify cell-speciﬁc differentially expressed genes (Supplementary
Dataset 6). The cell type with the greatest number of differentially
expressed genes was the proximal tubule (N = 607, padj < 0.05, |
avg_log2FC| > 0.25). Gene ontology analysis of differentially expressed
genes in the proximal tubule showed signiﬁcant overlap with snATACseq pathways, including membrane depolarization, anion homeostasis, sodium ion transport, and glucocorticoid signaling (Fig. 2B).
The diabetic proximal tubule showed a modest increase in expression
of GR (NR3C1, fold-change = 1.14, padj = 4.7 × 10−10), although it did not
meet the log-fold change threshold. The proximal tubule also showed
increased expression of sodium glucose cotransporter 2 (SGLT2, foldchange = 1.24, padj = 1.9 × 10−30) and increased expression of the ratelimiting enzyme in gluconeogenesis (PCK1, fold-change = 1.63, padj =
1.8 × 10−41). Similar to our ﬁndings from the snATAC-seq analysis, a
subset of differentially expressed genes were shared between multiple
cell types (Fig. 2C). These shared genes were enriched for pathways
involved in regulation of cell growth, cellular response to hypoxia,
angiogenesis, cellular response to insulin stimulus, glucocorticoid
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Transcribed cis-regulatory elements (tCRE) confer cell type speciﬁcity
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they overlap with ATAC peaks28,29. Transcriptional start sites (TSS) can
be identiﬁed by 5′ RNA sequencing if read 1 is long enough (>81 bp) to
include the junction between the template switch oligo (TSO) and TSS.
This type of analysis is compatible with single cell 5′ paired-end
chemistry (SC5P-PE, 10X Genomics), but will not work with libraries
that only use read 2 for alignment (SC5P-R2, 10X Genomics). We
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analyzed two control and two DKD snRNA-seq libraries with SC5P-PE
sequencing to identify de novo transcriptional start sites in CRE using
Single Cell Analysis of Five-prime Ends (SCAFE)30,31. SCAFE analyzes the
5′ end of RNA transcripts to identify reads mapping to the junction
between the TSO and cDNA sequence to localize TSS within tCRE after
ﬁltering false positives with a logistic regression classiﬁer. We
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Fig. 2 | snRNA-seq of human DKD. A UMAP of snRNA-seq dataset. Six control and
ﬁve DKD samples were aggregated, preprocessed, and ﬁltered. A total of 39,176
cells are depicted. PT-proximal tubule, PT_VCAM1-VCAM1(+) proximal tubule, PECparietal epithelial cells, ATL-ascending thin limb, TAL1-CLDN16(-) thick ascending
limb, TAL2-CLDN16(+) thick ascending limb, DCT1-early distal convoluted tubule,
DCT2-late distal convoluted tubule, PC-principal cells, ICA-type A intercalated cells,
ICB-type B intercalated cells, PODO-podocytes, ENDO-endothelial cells, MESmesangial cells and vascular smooth muscle cells, FIB-ﬁbroblasts, LEUK-leukocytes.
B Proximal tubule DEG pathway enrichment. Signiﬁcant cell-speciﬁc DEG from
proximal tubule were used to perform gene ontology enrichment with Panther.
Fold-enrichment for all signiﬁcant GO biological processes is shown and the top 25
are highlighted (Source data are provided as a Source Data ﬁle). C DEG in DKD that
are cell-speciﬁc or shared between cell types. DEG that were either shared between

multiple cell types or unique to a speciﬁc cell type are displayed. DEG shared
between multiple cell types are limited to groups that share ten or more DEG
(Source data are provided in Supplementary Dataset 6). D Proximal tubule shows
increased expression of gluconeogenic genes by snRNA-seq. Control proximal
tubule was compared to DKD proximal tubule in the snRNA-seq dataset to identify
differentially expressed genes with the FindMarkers function and visualized as
violin plots and dot plots. DKD proximal tubule showed increased expression of
PCK1, ALDOB, FBP1, and G6PC (see Supplementary Dataset 6 for adjusted p-values).
E Proximal tubule-speciﬁc DAR and ATAC peaks in PCK1. snATAC-seq coverage
plots for DKD and control PCT are displayed in relation to the PCK1 gene body.
Orange bars indicate multiple DAR that show decreased accessibility in diabetic
PCT (Supplementary Dataset 3). Green arcs depict the nodes of a cis-coaccessibility
network (CCAN) surrounding the PCK1 gene body.

identiﬁed 37,698 tCRE across all cell types (Fig. 3A, Supplementary
Dataset 8). The majority of tCRE were near a protein-coding TSS (mean
distance = 3823 +/− 43,885), but there was a signiﬁcant proportion of
tCRE in intronic (Fig. 3B, 11847/37,698, 31%) and intergenic regions
(Fig. 3B, 1367/37,698, 3%). Some of these tCRE may represent enhancer
RNA (eRNA), which are a family of non-coding RNA that regulate gene
expression and enhancer activity in a cell-speciﬁc manner32. The
majority of tCRE were overlapping with a snATAC-seq peak (Fig. 3C,
23,048/37,698, 61%) and approximately half of snATAC-seq DAR were
overlapping with a tCRE (494/968, 51%, hypergeometric test
p = 3.6 × 10−5). A small minority of tCRE were cell-type-speciﬁc (N = 361/
37,698, 1%, Supplementary Dataset 8), but correspond to well-known
cell-type-speciﬁc genes. For example, there was a cell-speciﬁc tCRE in
podocytes in the promoter region of NPHS1 and a cell-speciﬁc tCRE in
the proximal tubule in the promoter region of CUBN (Supplementary
Dataset 8). These data suggest that 5′ snRNA-seq datasets contain
complementary information that can be used to evaluate the activity of
CRE identiﬁed by snATAC-seq.
We compared control to DKD samples to identify cell-speciﬁc
differential tCRE in diabetes. Across all cell types, we detected a total of
293 differential tCRE (Supplementary Dataset 9). These tCRE included
139 unique regions, which were enriched for pathways involved in
mitochondrial electron transport and angiogenesis. Multiple cell types
showed increased transcription of CRE in promoters associated with
oxidative phosphorylation like MT-CO1, MT-CO2 and MT-CO3. We also
compared the proximal tubule to PT_VCAM1 to identify tCRE that are
enriched in the PT_VCAM1 cell state (Supplementary Dataset 10).
Among 204 differential tCRE in PT_VCAM1, one of the most enriched
tCRE was the VCAM1 promoter (fold change = 1.46, padj = 1.1 × 10−82).
The VCAM1 promoter tCRE showed increased chromatin accessibility
in the corresponding snATAC dataset (Fig. 3D) and was associated with
two additional tCRE located ~60 kb upstream. Each of the upstream
tCRE were near a snATAC-seq peak and linked to the VCAM1 promoter
via a CCAN (Fig. 3D). We previously reported that this upstream CRE
binds NFkB by chromatin immunoprecipitation PCR3. NFkB signaling
induces VCAM1 expression in the proximal tubule, which raises the
possibility that NFkB binding to the upstream CRE is also associated
with transcription of enhancer RNA32,33. Together, these data suggest
that single cell analysis of 5′ ends may help to identify enhancers by
prioritizing CRE that are actively transcribed.

suggests that GR predominantly binds to areas of open chromatin in
the kidney (Fig. 4A). GR binding sites overlapped with cell-speciﬁc
ATAC peaks (N = 3066, 70%); many of which were shared between
multiple cell types. We visualized the intersection between cellspeciﬁc ATAC peaks and CUT&RUN sites to identify individual cell
types or groups of cells that share ten or more GR binding sites
(Fig. 4B). The presence of GR binding sites within cell-speciﬁc ATAC
peaks suggests GR signaling is controlled by chromatin accessibility
and regulated by distinct GR modules shared across cell types. For
example, there were GR binding sites in ATAC peaks unique to the
proximal tubule (N = 61, Fig. 4B column 2), unique to the distal
nephron (N = 13, Fig. 4B column 12), and shared between the proximal tubule and distal nephron (N = 26, Fig. 4B column 3). Similarly,
there were GR binding sites unique to lymphocytes (N = 15, Fig. 4B
column 13) and shared between the proximal tubule and lymphocytes (N = 21, Fig. 4B column 5).

Glucocorticoid receptor CUT&RUN in bulk kidney cortex
Cellular response to glucocorticoids is inﬂuenced by pre-existing
chromatin accessibility state where the majority of GR binding sites
localize to open chromatin regions34,35. We used cleavage under targets
and release using nuclease (CUT&RUN) to directly measure GR binding
in bulk kidney cortex obtained from a control donor36. We identiﬁed
4362 GR binding sites (Supplementary Dataset 11) located in promoter
regions (N = 2889, 66%), introns (N = 744, 17%) and distal intergenic
regions (N = 567, 13%). The density of cell-speciﬁc ATAC peaks closely
resembled the density of GR CUT&RUN sites across the genome, which
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Transcription factor motif enrichment and activity in the diabetic nephron
We used the JASPAR database to identify over-represented transcription factor motifs in cell-speciﬁc ATAC peaks and DAR in DKD37. Cellspeciﬁc ATAC peaks were enriched for established transcription factors that drive cell type differentiation like HNF4A in the proximal
tubule and TFAP2B in the distal nephron (Supplementary Dataset 12).
Transcription factors that were enriched in DAR provide insight into
cell-speciﬁc signaling pathways that are altered in DKD. PCT DAR were
signiﬁcantly enriched for NR3C1 and NR3C2 motifs (Supplementary
Dataset 13, NR3C1 fold enrichment = 2.1, p = 3.8 × 10−259; NR3C2 fold
enrichment = 2.1, p = 2.4 × 10−288). NR3C1 is the canonical binding motif
for GR and NR3C2 is the binding motif for MR. The presence of NR3C1
and NR3C2 motifs within PCT DAR suggests that chromatin accessibility may regulate corticosteroid signaling in the diabetic proximal
tubule38,39. We also saw enrichment of KLF9 and FOXO3 motifs within
PCT DAR, which are downstream of GR activation (Supplementary
Dataset 13). One of the most enriched motifs in PCT DAR was Histone
H4 transcription factor (HINFP, fold enrichment = 6.9, p = 6.3 × 10−308).
HINFP interacts with a component of the MeCP1 histone deacetylase
complex (HDAC) involved in transcriptional repression, which may
explain why the majority of DAR showed decreased chromatin
accessibility40. To help prioritize active signaling pathways in DKD, we
identiﬁed transcription factor motifs that were both differentially
expressed and enriched in DAR (Fig. 5A). HIF1A showed increased
expression and was enriched in DAR in multiple distal nephron cell
types (PC, ICA, DCT2) and PT_VCAM1. HIF1A is hypoxia inducible factor
1 subunit alpha, a master regulator of cellular response to hypoxia in
the kidney41. GR showed increased expression in the proximal tubule
(PT) and thick ascending limb (TAL1) where NR3C1 motifs were also
enriched in DAR. In contrast, MR showed decreased expression in the
distal nephron (PC, DCT2), but increased expression in the thick
ascending limb (TAL1). Together, these data suggest that corticosteroid signaling is altered in the diabetic proximal tubule and thick
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Fig. 3 | Transcribed cis-regulatory elements (tCRE) detected by 5-prime snRNAseq. A Distance from tCRE to TSS. Two control and two DKD samples were
sequenced with 5’ paired-end sequencing and analyzed with SCAFE. A total of
37,698 tCRE were annotated with ChIPSeeker and displayed relative to the nearest
TSS (Source data is provided as a Source Data ﬁle). B Annotation of tCRE. The
relative proportion of tCRE in promoters, introns, exons, distal intergenic, 3-prime,
and 5-prime regions is shown (Source data is provided as a Source Data ﬁle).
C Overlap between tCRE and ATAC peaks. tCRE were intersected with cell-speciﬁc
ATAC peaks and DAR in DKD using GenomicRanges. D Proximal convoluted tubule
and PT_VCAM1 DAR and ATAC peaks in VCAM1. snATAC-seq coverage plots for

PT_VCAM1 (green) and PCT (orange) are displayed in relation to the VCAM1 gene
body. The orange arrows indicate DAR that show either increased or decreased
accessibility in PT_VCAM1 relative to PCT (Supplementary Dataset 4). snATAC-seq
peaks accessible in the proximal tubule are displayed (snATAC peaks, gray boxes)
in the same track as PCT DAR (snATAC peaks, orange boxes). snRNA-seq tCRE
regions are displayed below snATAC-seq peaks and DAR (snRNA tCRE, gray boxes).
Differentially methylated regions (DMR) in publicly available databases associated
with end-stage kidney disease due to diabetes are shown as blue bars (see Methods). Green arcs depict the nodes of a cis-coaccessibility network (CCAN) surrounding the VCAM1 gene body.

ascending limb where multiple cell types may be exposed to a hypoxic
environment.
We used chromVAR to compare transcription factor activity
between control and diabetic cell types (Supplementary Dataset 14).
chromVAR is a tool for inferring transcription-factor-associated chromatin accessibility in single cells that helps to address sparsity inherent
in snATAC-seq datasets42. This is a qualitatively different and unbiased
approach when compared to transcription factor motif enrichment
analysis because it is not limited to a pre-speciﬁed list of cell-speciﬁc
DAR. Diabetic PCT showed decreased transcription factor activity for
NR3C1 (Fig. 5B, fold-change = 0.56, padj = 1.1 × 10−70) and increased
activity for REL motifs (Fig. 5B, fold-change = 2.08, padj = 6.9 × 10−212),
which was a pattern observed throughout the nephron. These data
support our transcription factor motif enrichment analysis by further
demonstrating that NR3C1 motifs localize to areas of decreased

chromatin accessibility in diabetes and REL motifs localize to areas of
increased accessibility.
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Glucocorticoid receptor footprinting with snATAC-seq and
CUT&RUN in RPTEC
We used the snATAC-seq dataset to perform transcription factor
footprinting for GR to visualize the relationship between NR3C1
motifs and chromatin accessibility. Across all cell types, there was a
well-deﬁned footprint immediately surrounding NR3C1 motifs
(Fig. 5C). DKD samples showed reduced chromatin accessibility
surrounding NR3C1 motifs, however, this effect was attenuated
when we limited our analysis to the proximal tubule (Fig. 5C). We
cultured immortalized renal proximal tubule epithelial cells
(hTERT-RPTEC, ATCC) and performed CUT&RUN to ﬁnd 22,539
consensus GR binding sites that were not present in IgG-stimulated
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Fig. 4 | Glucocorticoid receptor (GR) CUT&RUN in bulk kidney cortex. A Density
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were identiﬁed with the Seurat FindMarkers function (Supplementary Dataset 2)
and converted into a rainfall plot (green track) using the circlize package in R. Each
dot in the rainfall plot corresponds to a cell-speciﬁc ATAC peak and the y-axis
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cell-speciﬁc ATAC peaks (black track) and GR CUT&RUN peaks (purple track) are
shown adjacent to the rainfall plot using a 10 Mb default window size. B Upset plot
showing intersection between GR CUT&RUN sites and cell-speciﬁc ATAC peaks.
Each column of the Upset plot indicates a unique grouping of ATAC peaks that

intersect with bulk kidney GR CUT&RUN sites. The solid black circles in each column indicate which cell types are present within the intersection at the top of the
plot. For example, the ﬁrst column is a group of 14 ATAC peaks shared between
PCT, ENDO, B-cells, and T-cells that each contain a GR CUT&RUN site that is not
seen in other cell types. Only intersections with ten or more GR CUT&RUN sites are
included in the plot. GR CUT&RUN sites that do not intersect a cell-speciﬁc ATAC
peak are displayed as the black bar to the far right (N = 1296). The horizontal bars on
the right of the Upset plot represent the total number of peaks within each cell type
or GR CUT&RUN group (Source data is provided in Supplementary Dataset 2
and 11).

negative control samples (Supplementary Dataset 15). hTERTRPTEC media is supplemented with 25 ng/ml hydrocortisone (i.e.,
cortisol) and is a model of long-term glucocorticoid exposure.
Nearly half of PCT DAR (168/422, 39%) were overlapping with a GR
CUT&RUN site. These ﬁndings are comparable to the chromVAR
analysis, which showed that ~47% of control PCT and 35% of diabetic
PCT ATAC peaks contain an NR3C1 motif. GR binding sites that do
not directly overlap a PCT DAR may interact with DAR via CCAN
(Fig. 5D). For example, we identiﬁed multiple GR binding sites
throughout the FKBP5 gene body located in promoter and intronic
regions (Fig. 5E, Purple Boxes). Some of the GR binding sites in
FKBP5 co-localized with PCT DAR (Fig. 5E, Orange Box), but others
did not. FKBP5 expression was decreased throughout the entire
nephron (Fig. 5F), which highlights its potential importance in DKD
and raises the possibility that changes in chromatin accessibility
regulate its expression. The high proportion of overlap between GR
binding sites and snATAC-seq PCT DAR was especially striking given
that hTERT-RPTEC are a cell culture model that does not fully
recapitulate the normal proximal tubule. We proﬁled open chromatin regions in hTERT-RPTEC and primary RPTEC using OmniATAC and compared them to the PCT snATAC-seq dataset.
Approximately 59% of hTERT-RPTEC ATAC peaks (N = 57,675/
96,162, Supplementary Dataset 16) and 56% of primary RPTEC ATAC
peaks (N = 80,322/141,198, Supplementary Dataset 17) were overlapping with cell-speciﬁc PCT snATAC-seq peaks. These data
suggest that hTERT-RPTEC and primary RPTEC capture roughly half
of the chromatin accessibility proﬁle of a normal proximal
tubule cell.

Validation of differentially expressed genes in a bulk RNA-seq
dataset of human DKD

Nature Communications | (2022)13:5253

We analyzed a previously published bulk RNA-seq dataset of human
DKD to determine if our snRNA-seq ﬁndings are broadly generalizable.
The dataset published by Fan et. al consisted of 9 controls, 6 with early
DKD, and 22 with advanced DKD43. Early DKD was deﬁned as eGFR >
90 mL/min/1.73 m2 and UACR < 300 mg/g. Advanced DKD was deﬁned
as eGFR < 90 mL/min/1.73 m2 or UACR > 300 mg/g. According to this
deﬁnition, samples from our study would be categorized as advanced
DKD because all of them had either eGFR < 90 mL/min/1.73 m2 or
proteinuria. Another important difference between our study and the
study by Fan et al. is that mean eGFR of control samples from our study
(66 +/− 25 ml/min/1.73 m2) was signiﬁcantly less than eGFR of control
samples from their study (87 +/− 9.8 ml/min/1.73 m2, p = 0.03).
We compared the transcriptional proﬁle of advanced DKD to
control samples from Fan et al. to identify 9,632 differentially
expressed genes (Supplementary Dataset 18A, BH padj < 0.05).
Roughly half of these differentially expressed genes were upregulated
(N = 5181) and the remaining were downregulated (N = 4451). These
differentially expressed genes were enriched for familiar pathways
including amino acid metabolism, B cell receptor signaling, T cell differentiation, response to tumor necrosis factor, response to peptide
hormone, cellular response to hormone stimulus, and ion transmembrane transport. The enrichment of pathways involved in lymphocyte
signaling and differentiation likely reﬂects the greater proportion of
leukocytes present in DKD samples compared to control samples. We
previously demonstrated that advanced DKD samples from Fan et al.
contain an increased proportion of leukocytes and PT_VCAM13.
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Advanced DKD samples showed increased expression of GR (NR3C1,
fold-change = 1.16, padj = 0.02) and VCAM1 (fold-change = 1.36, padj =
0.006) and decreased expression of INSR (fold-change = 0.49, padj =
1.6 × 10−12), HSD11B2 (fold-change = 0.38, padj = 3.6 × 10−8) and FKBP5
(fold-change = 0.46, padj = 0.0009). Next, we compared early DKD
samples to controls to identify 1041 differentially expressed genes,
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among which 385 were upregulated and 656 were downregulated
(Supplementary Dataset 18B). The differentially expressed genes in
early DKD were enriched for pathways involved in response to epidermal growth factor, cellular response to glucocorticoids, cellular
response to insulin stimulus, and cellular response to tumor necrosis
factor. In contrast to the advanced DKD samples, we did not detect
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Fig. 5 | Glucocorticoid receptor (GR) binding and FKBP5 in DKD. A Cell-speciﬁc
transcription factor expression and motif enrichment. Transcription factors that
were both differentially expressed (Supplementary Dataset 6) and showed motif
enrichment in cell-speciﬁc DAR (Supplementary Dataset 13) were visualized. Cell
types that showed differential expression and motif enrichment for GR (NR3C1,
red), MR (NR3C2, blue), and HIF1A (HIF1A, black) motifs are highlighted. PTproximal tubule, PT_VCAM1-VCAM1(+) proximal tubule cells, PEC-parietal epithelial
cells, TAL1-CLDN16(-) thick ascending limb, TAL2-CLDN16(+) thick ascending limb,
DCT2-late distal convoluted tubule, PC-principal cells, ICA-type A intercalated cells.
B Cell-speciﬁc chromVAR motif activity for GR and REL. chromVAR was used to
compute cell-speciﬁc activities for NR3C1 and REL motifs for control and DKD. Red
arrows indicate signiﬁcantly decreased motif activity and green arrows indicate
increased activity (see Supplementary Dataset 14). C Transcription factor footprinting for GR. Transcription factor footprinting analysis was performed for
NR3C1 (GR) for all cell types and for PCT only to quantitate Tn5 insertion enrichment. D Interaction between PCT DAR and hTERT-RPTEC GR CUT&RUN sites. PCT

DAR in DKD (Supplementary Dataset 3) were intersected with cis-coaccessibility
networks (CCAN) to identify all CCAN links that contain at least one PCT DAR. These
regions were intersected with hTERT-RPTEC GR CUT&RUN sites and visualized with
the circlize package in R to identify links between GR CUT&RUN sites and PCT DAR.
E PCT-speciﬁc DAR and ATAC peaks in FKBP5. snATAC-seq coverage plots for DKD
and control PCT are displayed in relation to FKBP5. The orange arrow indicates a
DAR that shows decreased accessibility in DKD (Supplementary Dataset 3). PCTspeciﬁc ATAC peaks (Peaks, dark gray boxes) and DAR (Peaks, orange box) are
shown in relation to hTERT-RPTEC CUT&RUN sites (GR, purple boxes), differentially methylated regions (DMR) associated with end-stage kidney disease due to
diabetes (see Methods), and a cis-coaccessibility network (CCAN, green arcs) surrounding FKBP5. Blue stars indicate sites targeted by CRISPRi. F Cell-speciﬁc
expression of FKBP5 by snRNA-seq. Individual cell types were compared between
control and DKD and visualized to display relative change in FKBP5 expression. Red
arrows indicate decreased FKBP5 expression (see Supplementary Dataset 6 for
adjusted p-values).

differential expression of NR3C1, INSR, HSD11B2, or FKBP5 in early DKD
samples. This difference may reﬂect reduced speciﬁcity of bulk RNAseq and a limited number of early DKD samples (n = 6) vs. advanced
DKD samples (n = 22), or alternatively, that these genes are associated
with DKD progression.

not affect expression of neighboring genes expressed in primary
RPTEC (Fig. 6C). We hypothesize that CRISPRi simulates the effect of
hypermethylation, which leads to reduced chromatin accessibility.

Differentially methylated regions in DKD and CKD overlap with
cell-speciﬁc DAR and GR binding sites
We compiled a list of differentially methylated regions (DMR) from
previously published studies that compared methylation patterns
between DKD or CKD and control kidney samples44–48. Collectively,
these studies identiﬁed DMR associated with kidney disease progression that we compared to our cell-speciﬁc DAR and GR binding sites.
Approximately 9% of cell-speciﬁc DAR (N = 120/1315, 9.1%) were located within 1 kb of a DMR associated with ESKD due to diabetes, eGFR
decline in DKD, or interstitial ﬁbrosis in CKD and/or DKD (Supplementary Dataset 19). This overlap included 645 unique DMR enriched
for pathways involved in lipid homeostasis, amino acid transport, ion
transport, inﬂammatory response, and cellular response to hormone
stimuli. There were multiple DMR located within or near the INSR
(Fig. 1E), gluconeogenic genes (Supplementary Figs. 9–11), and FKBP5
(Fig. 5E), including DMR in the FKBP5 promoter that overlapped with a
PCT cell-speciﬁc DAR and GR binding site (Fig. 5E: orange arrow). All of
the FKBP5 DMR showed increased methylation in association with DKD
and FKBP5 was identiﬁed as a top-ranked gene with multiple differentially methylated CpGs supported by functional data and additional
cohorts45,48. Another notable DMR overlapped a cell-speciﬁc DAR in the
ATP1B1 promoter with a nearby a GR binding site (Supplementary
Figs. 5–6). A similar proportion of GR CUT&RUN peaks in bulk kidney
(N = 269/4362, 6,1%) and hTERT-RPTEC (N = 1537/22517, 6.8%) overlapped with DMR (Supplementary Dataset 19). Together these data
support the hypothesis that increased methylation in DKD and/or CKD
leads to decreased chromatin accessibility in key regulatory regions,
including GR binding sites near FKBP5.

CRISPRi knockdown of FKBP5 cis-regulatory elements

We selected two GR binding sites in the FKBP5 gene body (Fig. 5E, Blue
Stars) located at nodes within a CCAN (Fig. 5E, Green Arcs) to target
with CRISPRi. These GR binding sites intersected with DMR in publicly
available databases and a DAR in the FKBP5 promoter. Catalytically
inactive dCas9 fused to the Krüppel-associated box (KRAB) repression
domain (dCas9-KRAB) reduces chromatin accessibility to induce targeted gene silencing. We transduced primary RPTEC with sgRNA targeting the TSS or intronic CRE in FKBP5 to repress chromatin
accessibility with dCas9-KRAB (Fig. 6A)49. Transduction of sgRNAs
targeting the TSS or intronic region induced a 30–50% reduction in
FKBP5 expression compared to non-targeting control sgRNA (Fig. 6B).
Furthermore, gene silencing was speciﬁc to FKBP5 because CRISPRi did
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Partitioned heritability of Cell-speciﬁc ATAC peaks and differentially accessible regions for kidney-function-related GWAS
traits
GWAS have shown that a growing list of kidney-related traits have a
genetic component50–53. We downloaded GWAS summary statistics for
eGFR, CKD, microalbuminuria, and urinary sodium excretion to
determine whether cell-speciﬁc chromatin accessibility patterns
explain heritability of these traits. First, we partitioned heritability of
cell-speciﬁc ATAC peaks with stratiﬁed linkage disequilibrium score
regression to prioritize which cell types explain heritability of kidneyfunction-related traits after controlling for baseline enrichment54. The
cell types that showed the greatest enrichment for heritability of eGFR
after correction for multiple comparisons were segments of the
proximal tubule (PCT, PST) and the PT_VCAM1 population (Fig. 7A).
This relationship between proximal tubule and heritability of eGFR has
been previously described55. Interestingly, PT_VCAM1 cell-speciﬁc
peaks also showed increased heritability for CKD, which raises the
possibility that genetic background may inﬂuence the transition from
proximal tubule to PT_VCAM1 (Fig. 7A). Multiple segments of the thick
ascending limb (TAL1, TAL2) and principal cells (PC) showed enrichment for urinary sodium excretion, which is consistent with their
known roles in sodium reabsorption. In contrast, we did not identify
any cell types that showed increased heritability for microalbuminuria.
This may reﬂect our reduced sensitivity to detect podocyte-speciﬁc
ATAC peaks that may regulate this phenotype. Next, we partitioned
heritability for cell-speciﬁc DAR that change in DKD. Similar to the
ﬁndings from our cell-speciﬁc ATAC peak analysis, the DAR in the
proximal tubule showed increased heritability of eGFR (Fig. 7B). In
addition, DAR in the thick ascending limb (TAL1) showed increased
heritability of urine sodium excretion (Fig. 7B). These data suggest that
DKD induces changes in chromatin accessibility in some of the same
regions that predict heritability of cell-speciﬁc kidney functions. It also
raises the possibility that genetic background may modulate chromatin accessibility patterns to inﬂuence changes in eGFR or sodium
excretion in DKD.

Allele-speciﬁc chromatin accessibility as a modiﬁer of gene
expression
We created an open-source and containerized workﬂow for single-cell
allele-speciﬁc analysis called “SALSA ([https://github.com/p4rkerw/
SALSA])”. SALSA is a tool for genotyping, phasing, mapping bias correction, and modeling of single-cell allele-speciﬁc counts obtained
from snRNA-seq or snATAC-seq datasets. SALSA was developed from
an earlier pipeline that used direct genotyping of snRNA-seq and
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Fig. 6 | Knockdown of FKBP5 cis-regulatory elements with CRISPR interference.
A CRISPR interference diagram. dCas9-KRAB domain fusion protein and small
guide RNAs (sgRNA) were used to target the TSS and a potential intronic CRE
in the FKBP5 gene. Targeted regions are depicted as blue stars in the FKBP5
gene model diagram in Fig. 5E. sgRNA primers and region coordinates are
provided in Supplementary Dataset 21. B, C Quantitative PCR of CRISPRi. RT
and real-time PCR analysis of mRNAs for FKBP5 and surrounding genes
(MAPK14, PPARD, SPRK1 and TEAD3) in primary renal proximal tubular

epithelial cells (primary RPTEC) with CRISPR interference targeting the TSS
and predicted cis-regulatory element (CRE) for FKBP5. NT, non-targeting
control. Each group consists of n = 2 biologically independent experiments
each with n = 3 biological replicates (2 sgRNAs with 3 biological replicates).
Bar graphs represent the mean and error bars are the s.d. p-values are calculated with one-way ANOVA and a post-hoc Dunnett’s test for multiple comparisons. Statistical signiﬁcance was evaluated as an adjusted p-value < 0.05
(Source data are provided as a Source Data ﬁle).

snATAC-seq to explore allele-speciﬁc expression3. It has been updated
to include reference-based variant phasing, multithreading, generalized linear models for ASCA, user-friendly tutorials and a publicly
available Docker container built on the Genome Analysis Toolkit
(GATK) developed by the Broad Institute56. SALSA uses GATK best
practices for germline short-variant discovery to identify SNV and
indels, which are phased using shapeit4 and a population-based
reference from 1000 Genomes57,58. Phased variants present in the
population-based reference are used to perform mapping bias correction and eliminate technical artifacts with WASP59. Heterozygous
germline SNV that overlap ATAC peaks identify single-cell allele-speciﬁc peak fragments that map to either the reference or alternate allele.
In this manner, heterozygous SNV in ATAC peaks are used as markers
to assign a peak fragment to one haplotype or the other. This is an
attractive approach because the reference haplotype can serve as a
perfectly matched internal control for each individual. We quantitated
single-cell allele-speciﬁc peak fragments in the proximal tubule and
plotted the aggregate ratio of fragments mapping to reference or
alternate alleles among 43,479 peaks containing a heterozygous SNV
(Fig. 7C). The majority of peaks had an equal proportion of fragments
mapping to each allele (N = 35,019, 80%), but a minority of peaks had
allelic bias as evaluated by a binomial test (N = 8460, 20%). A signiﬁcantly smaller proportion of peaks met the adjusted p-value
threshold (N = 542, 1.2%), suggesting that most proximal tubule peaks
do not show allelic bias when aggregated across a population. Next, we
integrated snRNA-seq and snATAC-seq datasets to apply an algorithm
developed by Ma et al. to identify ATAC peaks that are correlated with
expression of nearby genes after correction for distance, GC content,
peak accessibility, and peak width60. This approach helped to identify
one or more gene targets for each peak containing a heterozygous
SNV. We developed a simple mixed effect logistic regression model
where the binary dependent variable was coded as the presence of an
alternate allele in an ATAC peak fragment and the continuous predictor variable was single cell target gene expression in the integrated
multimodal dataset. A mixed effect per sample was included to control

for pseudo-replication bias61. Our approach is a modiﬁcation of a
previously published model in SnapATAC used to identify geneenhancer pairs that coded the dependent variable as ‘open’ or ‘closed’
and omitted the mixed effect20. Our base model evaluates whether
increased or decreased expression of a target gene is predictive of the
presence of an alternate allele within an ATAC peak. In the simplest
terms, we can ask if the presence of a SNV in an ATAC peak is associated with changes in gene expression.
In the base model, we evaluated 66,828 peak-gene combinations
to estimate the effect of gene expression on the presence of a heterozygous SNV in an ATAC peak (Fig. 7D, Supplementary Dataset 20A).
The peak-gene combinations included 42,990 unique ATAC peaks
where the majority had either one (N = 28,989, 67%) or two gene targets (N = 8767, 20%). Approximately 11% of peak-gene combinations
showed nominal evidence of an allele-speciﬁc effect (Fig. 7D, 7512/
66,828, Wald test p < 0.05), which decreased to 1% after adjustment for
multiple comparisons (N = 714, 1%). There were 5,908 unique ATAC
peaks with at least one nominally signiﬁcant peak-gene allelic effect,
predominantly in promoter (N = 2312, 39%) and intronic regions
(N = 2082, 35%). The number of peak-gene combinations that showed
increased expression in association with an alternate allele (N = 3664,
48%) was similar to the number of combinations that showed
increased expression in association with the reference allele (N = 3848,
52%). Among peaks that met the signiﬁcance threshold, the median
absolute coefﬁcient value was 0.01 (log odds) for a 1% increase in target
gene expression. For a 10% increase in gene expression, this translates
to the typical ATAC peak being 1.10 times more likely to contain an
alternate allele in the base model. It is important to note that the base
model may overestimate the effect of expression on allele-speciﬁc
chromatin accessibility because it does not account for the role of
diabetes. In subsequent models, we added a ﬁxed effect for diabetes
(Model 2) and a ﬁxed effect for diabetes with an interaction term
between target gene expression and diabetes (Model 3). Model 2 had
7557 peak-gene combinations where expression was a nominally signiﬁcant predictor of the presence of an alternate allele (Supplementary
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Fig. 7 | Partitioned heritability of GWAS traits and predicted allelic effects with
SALSA. A Cell-speciﬁc analysis. Cell-type-speciﬁc ATAC peaks (Supplementary
Dataset 2) were partitioned for heritability of GWAS traits using the ldsc cell-typespeciﬁc workﬂow. Signiﬁcance was evaluated with a Benjamini-Hochberg-adjusted
one-sided test using padj < 0.05. N = 13 biologically independent samples containing 68,458 cells were examined in a joint analysis (Source data are provided as a
Source Data ﬁle). B Cell-speciﬁc DAR that change in DKD. Cell-speciﬁc DAR in DKD
(Supplementary Dataset 3) were analyzed with ldsc using the cell-type-speciﬁc
workﬂow. Signiﬁcance was evaluated as described above. C Ratio of snATAC-seq
fragments in the proximal tubule. SALSA was used to identify heterozygous SNV in
the proximal tubule (PCT, PST) and counts mapping to the reference or alternate
allele were aggregated across libraries and evaluated for allele-speciﬁc chromatin
accessibility using an exact binomial test (see Supplementary Dataset 20. D Predicting an allele-speciﬁc effect with SALSA. The presence of a fragment mapping to
an alternate allele in a proximal tubule peak (binary dependent variable) was

modeled as a function of target gene expression (continuous predictor variable)
after controlling for sample-to-sample variability with a mixed effect per library
using glmer in lme4. Effect size is displayed in log-odds where a 1 unit increase
corresponds to a 1% increase in gene expression. N = 11 biologically independent
samples containing 26,929 proximal tubule cells were examined in a joint analysis
(see Supplementary Dataset 20). E Partitioned heritability of proximal tubule peaks
with a predicted effect. Peaks that were associated with changes in target gene
expression were partitioned for heritability of eGFR for each of three generalized
linear mixed models in addition to peaks that met the binomial threshold for allelespeciﬁc chromatin accessibility. Signiﬁcance was evaluated with a BenjaminiHochberg-adjusted one-sided test using padj < 0.05. N = 11 biologically independent samples were examined in a joint analysis (Source data are provided as a
Source Data ﬁle). F Overlap between proximal tubule DAR and peaks with a predicted effect. DAR from PCT and PST were intersected with proximal tubule peaks
with a predicted effect in Model 3.

Dataset 20B, Wald test p < 0.05), which included 6980 that were also
identiﬁed in the base model. Since we know that diabetes can alter
gene expression, Model 3 included an interaction term between
expression and diabetes. Model 3 had 7353 peak-gene combinations

where expression was a nominally signiﬁcant predictor of the presence
of an alternate allele (Supplementary Dataset 20C, Wald test p < 0.05),
which included 4577 that were also identiﬁed in the base model.
Approximately 28% of these peak-gene combinations (N = 2097/7353)
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had a nominally signiﬁcant interaction between expression and diabetes. In addition, diabetes was a nominally signiﬁcant predictor of the
presence of an alternate allele in 20% of peak-gene combinations
(N = 1471/7353) after adjusting for gene expression. To examine the
reproducibility of allele-speciﬁc effects, we analyzed peak-gene combinations in the proximal tubule for individual donors using the base
model, but omitting the mixed effect. Across donors, we identiﬁed
24,794 nominally signiﬁcant peak-gene combinations that were present in at least one donor. Approximately half of these peak-gene
combinations (n = 10,495, 42%) were nominally signiﬁcant in two or
more donors. Two-thirds of the peak-gene combinations that were
identiﬁed in multiple donors had an effect size in the same direction
(n = 7121/10,495, 67%), suggesting that the presence of a variant in an
ATAC peak may have similar effects across individuals.
We hypothesized that peaks with a predicted allele-speciﬁc
effect would be enriched for heritability of kidney-function-related
traits in the proximal tubule. We partitioned heritability for eGFR
using peaks that met the nominal p-value threshold (Wald test
p < 0.05) for the expression ﬁxed effect in each of three models. All
three models showed increased heritability for eGFR (Fig. 7E). In
contrast, proximal tubule ATAC peaks that showed increased proportion of fragments mapping to the alternate or reference allele
(Fig. 7C) in the aggregated dataset did not have enrichment for
heritability of eGFR (ASCA, Fig. 7D). These peaks do not necessarily
have a predicted allele-speciﬁc effect and may represent a random
subset of proximal tubule peaks that exhibit biased chromatin
accessibility due to chance alone. These data suggest that peaks with
a predicted allele-speciﬁc effect are more likely to contribute to
heritability of eGFR than a random sampling of proximal tubule
peaks. Approximately 20% of proximal tubule DAR were overlapping
with a peak with a predicted allelic effect (N = 104/597, Fig. 7E,
Hypergeometric p = 1.7 × 10−10), suggesting that genetic background
may also modify chromatin accessibility patterns in DKD. We used
the 4476 signiﬁcant peak-gene combinations present in all three
models to perform gene ontology enrichment. The most enriched
pathways involved peptide antigen assembly with MHC class II,
antigen processing, and immunoglobulin production. Each of these
pathways involve multiple HLA genes, which are known to exhibit
allele-speciﬁc expression due to genetic variation in CRE62. Proximal
tubule expression of MHC class II regulates the response to kidney
injury and renal ﬁbrosis63. Additional enriched pathways with
important function in the proximal tubule included triglyceride
metabolism, amino acid transport, and carbohydrate metabolism.

Discussion
DKD progression is multifactorial and contributing factors include
hyperglycemia, hypertension, hypoxia, and inﬂammation64. These
factors exert their effect on different cell types throughout the
nephron, which organizes a coordinated response to tissue injury. DKD
was associated with an increased proportion of VCAM1 + proximal
tubule cells (PT_VCAM1) and inﬁltrating leukocytes in both snRNA-seq
and snATAC-seq datasets. The PT_VCAM1 cell state emerges after
proximal tubule injury and is associated with acute kidney injury,
aging, and DKD3,65. It adopts a pro-inﬂammatory phenotype characterized by enhanced NFκB signaling and failed repair that may
underlie transition from acute kidney injury to CKD66. In our dataset,
there was another closely related proximal tubule cluster that we
termed PT_PROM1. PT_PROM1 is characterized by a PROM1high VCAM1chromatin accessibility proﬁle that differentiates it from PT_VCAM1,
which is PROM1low VCAM1+. These data are consistent with recent
reports that there are multiple proximal tubule injury states and raises
the question whether they have variable effects on kidney disease
progression67. These cell states are not speciﬁc to DKD because they
are observed in control kidney, however, we hypothesize that DKD
leads to an increase in their abundance.
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GR signaling is a key regulator of the immune response and
exerts its effects on multiple cell types in the kidney. GR has potent
anti-inﬂammatory properties that help mitigate tissue injury, but
long-term exposure to glucocorticoids can lead to insulin resistance
and metabolic syndrome68. Chromatin accessibility pre-determines
cellular response to glucocorticoids and GR preferentially binds
areas of open chromatin35. Our snATAC-seq analysis showed that the
majority of DAR in DKD had reduced chromatin accessibility and
were enriched for GR motifs across multiple cell types. These data
suggest that the diabetic nephron is pre-programmed to respond
differently to corticosteroids. Metabolic memory is an epigenetic
state characterized by persistent expression of DKD-related genes
despite glycemic control21. Decreased chromatin accessibility of GR
binding sites within GR-responsive genes can lead to reduced transactivation and expression of target genes, however, DNA-bindingindependent mechanisms may remain intact. GR directly binds proinﬂammatory transcription factors like NFκB to inhibit their activity
in a process called tethering69. In a simple model, the metabolic
effects of GR signaling can be attributed to transactivation and the
anti-inﬂammatory effects can be attributed to tethering70,71. We
hypothesize that the diabetic kidney adapts to a pro-inﬂammatory
environment by remodeling chromatin accessibility to promote antiinﬂammatory effects of GR at the expense of its adverse effects on
metabolism. Targeting GR signaling in the proximal tubule may help
to decrease GR-mediated gluconeogenesis and improve glycemic
control, particularly during fasting. SGLT2i have been shown to
increase gluconeogenesis, which raises the possibility that GR inhibition may be useful as a combination therapy, however, further
studies will be needed to evaluate this hypothesis70,72,73.
We used CUT&RUN to identify GR binding sites in the proximal
tubule and validate predictions from our snATAC-seq analysis. GR
binding sites showed signiﬁcant overlap with proximal-tubule-speciﬁc
ATAC peaks and participated in CCAN with cell-speciﬁc DAR in diabetes. A subset of GR CUT&RUN sites showed reduced chromatin
accessibility in the proximal tubule, suggesting that it may respond
differently to glucocorticoids. Changes in GR signaling were compounded by increased expression of GR, and reduced expression of
FKBP5 and HSD11B2 in diabetes. FKBP5 is a cytosolic chaperone that
negatively regulates GR signaling as part of a negative feedback loop
and HSD11B2 converts cortisol into inactive cortisone to protect nonselective activation of MR74. We found DAR within FKBP5 that coincide
with GR binding sites within a CCAN. CRISPRi targeting of GR binding
sites decreased FKBP5 expression, suggesting that DKD is associated
with reduced activity of GR negative feedback in the proximal tubule.
FKBP5 methylation has been associated with type 2 diabetes and cardiovascular risk and FKBP5 polymorphisms are associated with insulin
resistance75,76. Publicly available datasets of differentially methylated
regions (DMR) associated with CKD and/or DKD progression overlapped with cell-speciﬁc DAR and GR CUT&RUN sites from our study.
These data support the hypothesis that FKBP5 hypermethylation leads
to reduced chromatin accessibility in GRE and reduced activity of the
GR negative feedback loop (Fig. 8).
The diabetic proximal tubule had increased gluconeogenesis,
which is downstream of GR signaling. The proximal tubule is the primary site in the kidney for glucose production and its rate-limiting
enzyme is PCK177. We saw increased expression of PCK1 and other
gluconeogenic enzymes in the diabetic proximal tubule that was
associated with reduced expression of INSR. Glucose reabsorption and
glucose production are closely intertwined and tightly regulated by
insulin signaling78. Proximal-tubule-speciﬁc INSR knockout and
proximal-tubule-speciﬁc IRS1/2 knockout have both been shown to
increase gluconeogenesis, which is normally suppressed by insulin
signaling or glucose reabsorption via SGLT278,79. Glutamine is the
preferred substrate for gluconeogenesis in the proximal tubule, which
leads to ammonia production and acid excretion to maintain acid-base
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Fig. 8 | Model of altered glucocorticoid receptor signaling in the diabetic
proximal tubule. GR expression is increased in the diabetic proximal tubule.
Cortisol binds GR and translocates to the nucleus where it localizes to glucocorticoid response elements (GRE) in genes like FKBP5. Decreased chromatin accessibility of GRE in the FKBP5 gene body is observed as reduced accessibility of
proximal-tubule-speciﬁc ATAC peaks in DKD (red triangles). Reduced accessibility
of FKBP5 GRE leads to reduced transactivation by GR and reduced FKBP5

expression. Reduced FKBP5 expression decreases activity of the GR negative
feedback loop. In the absence of FKBP5 negative feedback, GR can exert both DNAbinding-dependent and DNA-binding-independent actions that lead to adverse
metabolic effects, anti-inﬂammatory effects, and increased gluconeogenesis. GR
hallmark pathway genes that are differentially expressed in our study include:
CDKN1A, CREBBP, EGR1, FKBP5, FOS, HSP90AA1, ICAM1, JUN, MAPK10, NCOA2, NFKB1,
NR3C1, NR4A1, PBX1, PCK2, PRKACB, SGK1, SMARCA4, STAT1, STAT5A, STAT5B.

balance during prolonged fasting. It is possible that gluconeogenesis is
upregulated in DKD to promote acid excretion and mitigate metabolic
acidosis80. SGLT2i stimulate gluconeogenesis in the liver and kidney,
however, it remains unclear whether gluconeogenesis affects DKD
progression72,73,78.
Genetic background is increasingly recognized as an important
determinant of kidney function and DKD10,50,53. GWAS are generating
a growing list of variants associated with kidney function, but it
remains difﬁcult to associate these variants with regulation of a
speciﬁc gene or pathway. Bioinformatics approaches have led to the
identiﬁcation of quantitative trait loci associated with expression
(eQTL), chromatin accessibility (caQTL), methylation (meQTL), and
other traits that may regulate kidney function in a cell-speciﬁc
manner14. Some of these phenotypes are driven by allele-speciﬁc
effects that can be measured as changes in expression (ASE) and
chromatin accessibility (ASCA)3,19,81. Allele-speciﬁc analysis can substantially boost the power of QTL studies because each individual
serves as its own perfectly matched control. Multimodal single-cell
datasets can take advantage of this approach to model allele-speciﬁc
effects as a function of gene expression (or any other measurable
quantity). We developed a tool for single cell allele-speciﬁc analysis
called SALSA and used it to detect proximal-tubule-speciﬁc ATAC
peaks in CRE that modify gene expression via ASCA. These peaks
were enriched for heritability of eGFR and some of them coincide
with DAR in DKD. These ﬁndings raise the possibility that genetic
background affects kidney function via ASCA, which could alter the
progression of DKD.

An additional three kidney cortex samples (1 control and 2 DKD) were
obtained from deceased organ donors in the Novo Nordisk biorepository. For bulk kidney GR CUT&RUN and Omni-ATAC, kidney
cortex samples were obtained from deceased organ donors (N = 3)
under an established Institutional Review Board protocol approved by
Washington University in St. Louis. All participants provided written
informed consent in accordance with the Declaration of Helsinki,
including publication of demographic and clinical history as included
in Supplementary Dataset 1. Histologic sections were reviewed by a
renal pathologist and laboratory data was abstracted from the medical
record.

Methods
Human kidney tissue
This research complies with all relevant ethical regulations and has
been approved by the Washington University Institutional Review
Board. For snRNA-seq and snATAC-seq, non-tumor kidney cortex
samples (n = 10) were obtained from patients undergoing partial or
radical nephrectomy for renal mass at Brigham and Women’s Hospital
(Boston, MA) under an established Institutional Review Board protocol
approved by the Mass General Brigham Human Research Committee.
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Statistics and reproducibility
Statistical analysis was conducted on all collected samples and data
and carried out in Docker containers to enhance reproducibility. The
details of each analysis is outlined in the methods section. No statistical
method was used to predetermine sample size. No data were excluded
from the analyses. The experiments were not randomized. Investigators were not blinded to allocation during experiments and outcome
assessment.

Nuclear dissociation and library preparation
Samples were chopped into <2 mm pieces, homogenized with a
Dounce homogenizer (885302–0002; Kimble Chase) in 2 ml of icecold Nuclei EZ Lysis buffer (NUC-101; Sigma-Aldrich) supplemented
with protease inhibitor (5892791001; Roche) with or without RNase
inhibitors (Promega, N2615 and Life Technologies, AM2696, only for
snRNA-seq library preparation), and incubated on ice for 5 min. The
homogenate was ﬁltered through a 40-μm cell strainer (43–50040–51;
pluriSelect) and centrifuged at 500 × g for 5 min at 4 °C. The pellet was
resuspended, washed with 4 ml of buffer, and incubated on ice for
5 min. Following centrifugation, the pellet was resuspended in Nuclei
Buffer (10 × Genomics, PN-2000153) for snATAC-seq, nuclei suspension buffer (1× PBS, 1% bovine serum albumin [BSA], 0.1% RNase inhibitor) for snRNA-seq, or 1× PBS containing 1% BSA for CUT&RUN. The
suspension was then ﬁltered through a 5-μm cell strainer (43-5000503, pluriSelect) and counted.
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Single nucleus ATAC sequencing and bioinformatics workﬂow

Single nucleus RNA sequencing and bioinformatics workﬂow

Thirteen snATAC-seq libraries were created with 10X Genomics
Chromium Single Cell ATAC v1 chemistry following nuclear dissociation. These libraries included six control and seven DKD samples. Five
of the control snATAC-seq libraries were prepared for a prior study
(GSE151302). A target of 10,000 nuclei were loaded onto each lane.
Sample index PCR was performed at 12 cycles. Libraries were
sequenced on an Illumina Novaseq instrument, demultiplexed with
bcl2fastq, and counted with cellranger-atac v2.0 (10X Genomics) using
GRCh38. Libraries were aggregated with cellranger-atac without depth
normalization. A mean of 327,328,680 reads were sequenced for each
snATAC library (s.d. = 47,171,305) corresponding to a median of 15,150
fragments per cell (s.d. = 3875). The mean fraction of reads with a valid
barcode was 96.3 ± 2.2%. Aggregated datasets were processed with
Seurat v4.0.3 and its companion package Signac v1.3.0. A Seurat object
was created using the CreateSeuratObject function with min.cells=10
and min.features=200. Low-quality cells were removed from the
aggregated snATAC-seq dataset (peak region fragments > 2500, peak
region fragments < 20,000, nucleosome signal < 4, TSS enrichment >
2) before normalization with term-frequency inverse-documentfrequency (TFIDF) with default parameters. Dimensional reduction
was performed via singular value decomposition (SVD) of the TFIDF
matrix. Batch effect was corrected with Harmony using the RunHarmony function in Seurat and the lsi reduction. Dimensional reduction
was performed with the FindNeighbors function using dimensions
2:30 and clustered using the FindClusters function with the Louvain
algorithm. UMAP was performed using the harmony reduction and
dimensions 2:30. Homotypic and heterotypic doublets were identiﬁed
by running AMULET (v1.1.0) on individual snATAC-seq libraries and
visualized in the aggregated object prior to removal of doublets with a
qval < 0.0524. A gene activity matrix was constructed by counting ATAC
peaks within the gene body and 2 kb upstream of the transcriptional
start site using protein-coding genes annotated in the Ensembl database. The gene activity matrix was log-normalized prior to label
transfer with the aggregated snRNA-seq Seurat object using canonical
correlation analysis. The aggregated snATAC-seq object was ﬁltered
using label transfer to remove additional heterotypic doublets not
captured by AMULET. Cell-speciﬁc ATAC peaks were called with
MACS2 (v2.2.7.1) using the Signac wrapper with default parameters
and a new Seurat object was created using MACS2 peaks and the
FeatureMatrix function. The new snATAC-seq object was reprocessed
with TFIDF, SVD, and batch effect correction followed by clustering
and annotation based on lineage-speciﬁc gene activity as previously
described. After ﬁltering, there was a mean of 6000 ± 1134 nuclei per
snATAC-seq library with a mean of 8098 ± 3231 peaks detected per
nucleus. The ﬁnal snATAC-seq library contained a total of 437,311
unique peak regions among 68,458 nuclei and represented all major
cell types within the kidney cortex. Representative quality control
plots and visualization of sample integration are in Supplementary
Fig. 12. Differential chromatin accessibility between cell types was
assessed with the Signac FindMarkers function for peaks detected in at
least 20% of cells using a likelihood ratio test. Bonferroni-adjusted pvalues were used to determine signiﬁcance at an FDR < 0.05. Genomic
regions containing snATAC-seq peaks were annotated with ChIPSeeker
(v1.5.1) and clusterProﬁler (v4.0.5) using Ensembl and FANTOM databases on hg38. Motif enrichment within DAR was calculated with the
Signac FindMotifs function using cell-speciﬁc accessible peaks matched for GC content with TFBSTools (v1.39.0) and motifmatchr
(1.14.0). chromVAR (1.14.0) motif activities were computed using the
Signac wrapper and JASPAR2020 database (v0.99.10) adjusted for the
number of fragments in peaks for each nucleus. CCAN were computed
with cicero (v1.3.4.11) using the run_cicero function and default parameters. Gene-enhancer links were computed with the Signac LinkPeaks function and imputed RNA following label transfer and
integration of snRNA-seq and snATAC-seq datasets.

Eleven snRNA-seq libraries were obtained using 10X Genomics Chromium single cell chemistry following nuclear dissociation. Eight
snRNA-seq libraries (5 control, 3 DKD) were prepared for prior studies
(GSE131882, GSE151302). A target of 10,000 nuclei were loaded onto
each lane. The cDNA for snRNA libraries was ampliﬁed for 17 cycles.
Libraries were sequenced on an Illumina Novaseq instrument, demultiplexed with bcl2fastq, and counted with cellranger v4.0 using a
custom pre-mRNA GTF built on GRCh38 to include intronic reads.
Datasets were aggregated with cellranger v4.0 without depth normalization. A mean of 382,207,065 reads (s.d. = 78,522,614) were
sequenced for each snRNA library corresponding to a mean of 68,429
reads per cell (s.d. = 21,706). The mean sequencing saturation was
77.6 ± 11.9%. The mean fraction of reads with a valid barcode (fraction
of reads in cells) was 75.9 ± 6.6%. Aggregated datasets were preprocessed with Seurat v4.0.3 to remove low-quality nuclei (Features > 500, Features < 5000, RNA count < 16000, %Mitochondrial
genes < 0.5, %Ribosomal protein large or small subunits < 0.3) and
DoubletFinder v2.0.3 to remove heterotypic doublets (assuming 6% of
barcodes represent doublets). The ﬁltered library was normalized with
SCTransform using default parameters and corrected for batch effects
with Harmony v0.1.0 using the RunHarmony function in Seurat with
the SCT assay. After ﬁltering, there was a mean of 3561 ± 2028 cells per
snRNA-seq library and a mean of 2137 ± 1031 genes detected per
nucleus. Representative quality control plots and visualization of
sample integration are in Supplementary Fig. 13. Clustering was performed by constructing a KNN graph with the Louvain algorithm using
dimensions 1:24 and a resolution of 0.8. Dimensional reduction was
performed with the RunUMAP function using dimensions 1:24 and
individual clusters were annotated based on the expression of lineagespeciﬁc markers. The ﬁnal snRNA-seq library contained 39,176 cells
and represented all major cell types within the kidney cortex. Differential expression between cell types was assessed with the Seurat
FindMarkers function for transcripts detected in at least 20% of cells.
Bonferroni-adjusted p-values were used to determine signiﬁcance at an
FDR < 0.05.
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Single cell analysis of ﬁve-prime ends with SCAFE
We used SCAFE (1.0) to analyze single nucleus 5′ paired-end chemistry
libraries obtained from two DKD samples and two previously published
control samples (GSE151302)30. Transcribed cis-regulatory elements
(tCRE) were called in individual libraries using the scafe.worfklow.sc.solo
function with default parameters. There was a mean of 16,912 tCRE per
library (s.d. = 1855). Libraries were pooled with the scafe.workﬂow.sc.pool function to identify a total of 37,698 tCRE. Pooled libraries were
merged into a Seurat object followed by normalization with SCTransform, batch effect correction with Harmony, dimensional reduction,
and clustering. The ﬁnal object contained 10,984 nuclei and cell types
were annotated using snRNA-seq barcode annotations from the same
samples (see snRNA-seq bioinformatics workﬂow above). Cell-speciﬁc
tCRE and differential tCRE in diabetes were identiﬁed with the FindMarkers function with a log-fold-change threshold of 0.25. Bonferroniadjusted p-values were used to determine signiﬁcance at an FDR < 0.05
and signiﬁcant tCRE were annotated with ChIPseeker.

Cell culture
Human primary proximal tubular cells (human RPTEC, Lonza; CC2553) were cultured with renal epithelial cell growth medium kit
(Lonza; CC-3190). Human telomerase reverse transcriptase (hTERT)immortalized human RPTEC (ATCC; CRL-4031) were cultured with
ATCC hTERT Immortalized RPTEC Growth Kit (ATCC, ACS-4007).
HEK293T cells (ATCC; CRL-3216) were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM, Gibco; 11965092) supplemented with 10%
fetal bovine serum (Gibco; 10437028) and antibiotics. All cultured cells
were maintained in a humidiﬁed 5% CO2 atmosphere at 37 °C.
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GR CUT&RUN library preparation and peak calling
CUT&RUN assay libraries for cultured cells or human kidneys were
generated using the CUTANA kit (EpiCypher, 14-1048) with the manufacturer’s instructions. For cultured cells, adherent cells were scraped
from culture dishes and centrifuged at 500 × g for 5 min. Pellets were
resuspended in PBS with 1% BSA and counted. Cultured cells or nuclei
obtained from a human kidney (500,000 cells or nuclei) were then
mixed and incubated with Concanavalin A (ConA) conjugated paramagnetic beads. Antibodies were added to each sample (0.5 μg of
rabbit glucocorticoid receptor antibody [abcam, ab225886, 1:20] or
rabbit IgG negative control antibody [Epicypher, 13-0041k, 1:50]). The
remaining steps were performed according to the manufacturer’s
instructions. Library preparation was performed using the NEBNext
Ultra II DNA Library Prep Kit for Illumina (New England BioLabs,
E7645S) with the manufacturer’s instructions, including minor modiﬁcations indicated by CUTANA described above. CUT&RUN libraries
were sequenced on a NovaSeq instrument (Illumina, 150 bp paired-end
reads). Fastq ﬁles were trimmed with Trim Galore (Cutadapt [v2.8])
and aligned with Bowtie2 [v2.3.5.1] (parameters: --local --very-sensitivelocal --no-unal --no-mixed --no-discordant --phred33 -I 10 -X 700) using
hg38. Peak calling was performed using MACS2 [v2.2.7.1] with default
parameters using samtools (1.9) and DeepTools (3.5.0). Bulk human
kidney GR CUT&RUN had a mean of 24,693,221 reads (SD = 2,921,074
reads) with 62% on-target alignments and an estimated duplication
rate of 0.36. Bulk human kidney IgG CUT&RUN control samples had a
mean of 26,162,676 reads (SD = 1,477,128 reads) with 63% on-target
alignments and an estimated duplication rate of 0.39. hTERT-RPTEC
GR CUT&RUN had a mean of 21,647,282 reads (SD = 4,205,002 reads)
with 75% on-target alignments and an estimated duplication rate of
0.26. hTERT-RPTEC IgG CUT&RUN control samples had a mean of
22,770,072 reads (SD = 140,623) with 66% on-target alignments and an
estimated duplication rate of 0.35.

Bulk ATAC-seq library preparation and peak calling
We suspended 50,000 cells in 50 μL of ice-cold lysis buffer with 10 mM
Tris-HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl2, 1% BSA, 0.1% Tween-20
(Sigma, P7949-100ML), 0.1% NP-40 (Thermo Scientiﬁc, 28324) and
0.01% Digitonin (Thermo Scientiﬁc, BN2006)82. The suspension was
incubated for 4 min on ice. Subsequently, 450 μL of ice-cold wash
buffer (10 mM Tris-HCl [pH 7.4], 10 mM NaCl, 3 mM MgCl2, 1% BSA,
0.1% Tween-20) was added and centrifuged at 600 × g for 6 min. The
pellet was resuspended in 25 μL of ATAC-seq transposition mix (12.5 μL
2 × Illumina Tagment DNA (TD) buffer; 10.5 μL nuclease-free water;
2.0 μL Tn5 transposase [Illumina, FC-121-1030]) and incubated at 37 °C
for 1 h on a thermomixer. The transposed DNA was puriﬁed with
MinElute PCR puriﬁcation kit (QUIAGEN, 28004). DNA samples were
then ampliﬁed with PCR ([72 °C; 5 min] and [98 °C; 30 s] followed by 9
cycles of [98 °C; 10 s, 63 °C; 30 s, 72 °C; 1 min] using unique 10-bp dual
indexes and NEBNext High-Fidelity 2 × PCR Master Kit (M0541L). Following the ﬁrst ampliﬁcation, DNA size selection was performed using
solid-phase reversible immobilization (SPRI) beads (AMPure XP
[Beckman Coulter, A63881]) at an SPRI to DNA ratio of 0.5. The
supernatant was further mixed with SPRI beads at a SPRI to DNA ratio
of 1.2. The resulting supernatant was discarded, and the magnetimmobilized SPRI beads were washed twice with 80% ethanol. DNA was
subsequently eluted in 20 μL of EB elution buffer (QUIAGEN, included
in 28004). The size-selected DNA was ampliﬁed with an additional
9-cycle PCR. Subsequently, the ampliﬁed DNA was puriﬁed with
Ampure XP (SPRI to DNA ratio of 1.7) and eluted with 25 μL of buffer EB
elution buffer. The resultant ATAC-seq libraries were sequenced on a
NovaSeq instrument (Illumina, 150 bp paired-end reads). Fastq ﬁles
were trimmed with Trim Galore (Cutadapt [v2.8]) and aligned with
Bowtie2 [v2.3.5.1] with --very-sensitive -X 2000 using hg38. PCR
duplicates were removed with Picard’s MarkDuplicates function. Peak
calling was performed on each sample separately using MACS2
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[v2.2.7.1] (--nomodel --shift −100 --extsize 200). The consensus list of
accessible peaks was generated using the intersect function in bedtools. hTERT-RPTEC libraries were sequenced to a mean depth of
58,250,870 reads (SD = 13,029,194 reads) with 98% on-target alignments and an estimated duplication rate of 0.21. Primary RPTEC were
sequenced to a mean depth of 67,220,749 reads (SD = 18,879,089
reads) with 98% on-target alignments and an estimated duplication
rate of 0.24.

CRISPR interference
Small guide RNA (sgRNA) targeting around the FKBP5 TSS and intronic
CRE were designed with CHOPCHOP (https://chopchop.cbu.uib.no/).
These sgRNAs and two non-targeting control sgRNAs were placed
following the U6 promoter in a dCas9-KRAB repression plasmid (pLV
hU6-sgRNA hUbC-dCas9-KRAB-T2a-Puro, Addgene; 71236, a gift from
Charles Gersbach) with golden gate assembly. The sgRNA sequences
used in this study are in Supplementary Dataset 21. First, single-strand
oligonucleotides (Integrated and Technology [IDT]) for sense and antisense sequences were annealed. Subsequently, cloning with Golden
gate assembly was performed with Esp3I restriction enzyme (NEB,
R0734L) and T4 DNA ligase (NEB, M0202L) on a thermal cycler
repeating 37 °C for 5 min and 16 °C for 5 min for 60 cycles, followed by
transformation to NEB 5-alpha Competent E. coli (NEB, C2987H) per
manufacturer’s instructions. The cloned lentiviral vectors were puriﬁed with a mini high-speed plasmid kit (IBI Scientiﬁc; IB47102).
Insertion of sgRNA was checked with Sanger sequencing. For lentivirus
preparation, we seeded 6.0 × 105 HEK293T cells per well on six-well
tissue culture plates 16 h prior to transfection. Cells were transfected
with 1.5 µg of psPAX2 (Addgene; 12260, a gift from Didier Trono),
0.15 µg of pMD2.G (Addgene; 12259, a gift from Didier Trono) and 1.5 µg
of dCas9-KRAB repression plasmid per well by Lipofectamine 3000
transfection reagent (Invitrogen; L3000015) per manufacturer’s
instructions. Culture media were changed to DMEM supplemented
with 30% FBS 24 h after transfection. Lentivirus-containing supernatants were harvested 24 h later and ﬁltered with 0.45 µm PVDF ﬁlters
(CELLTREAT; 229745). The lentivirus-containing supernatants were
immediately used for lentiviral transduction. Human RPTEC were
seeded at 5.0 × 104 cells per well on 6-well tissue culture plates 16 h
prior to transfection. The media on human RPTEC was then changed to
the fresh lentiviral supernatants supplemented with polybrene (5 µg/
ml, Santa Cruz Biotechnology; sc-134220) and cultured for 24 h. Subsequently, RPTEC cells were cultured in renal epithelial cell growth
medium and puromycin (3 µg/ml, invivogen; ant-pr-1) for 72 h.

Quantitative PCR
RNA from human RPTECs was extracted with the TRIZOL and Directzol MicroPrep Plus Kit (Zymo) following the manufacturer’s
instructions. Extracted RNA (1-2 µg) was used for reverse transcription to generate cDNA libraries with the High-Capacity cDNA Reverse
Transcription Kit (Life Technologies). Quantitative PCR was performed in the BioRad CFX96 Real-Time System using iTaq Universal
SYBR Green Supermix (Bio-Rad). Expression levels were normalized
to GAPDH, and data were analyzed using the 2-ΔΔCt method. Quantitative PCR data are presented as mean±s.d. and compared between
groups with one-way ANOVA and a post-hoc Dunnett’s adjustment
for multiple comparisons. A p-value < 0.05 was considered statistically signiﬁcant. Primer sequences are provided in supplementary
materials (Supplementary Dataset 21).

Bulk RNA-seq analysis of previously published human DKD
Raw fastq ﬁles were downloaded from GSE142025 to include 9 control,
6 early DKD, and 22 advanced DKD donors43. Transcript abundance
was quantiﬁed with Salmon (1.8.0) using Ensembl (release-99) and
count matrices were imported to DESeq2 (1.32.0) with tximport
(v1.16.1). Differentially expressed genes were identiﬁed using the
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DESeq function with default parameters for early DKD vs. Control and
advanced DKD vs. Control (Supplementary Dataset 18). Signiﬁcance
was determined using a Benjamini-Hochberg adjusted p-value.

Comparison of Cell-speciﬁc DAR and GR binding sites to differentially methylated regions in CKD or DKD
Differentially methylated regions (DMR) were downloaded from publicly available databases comparing control kidney samples to CKD or
DKD44–48. DMR were lifted over to hg38 coordinates using the UCSC
LiftOver utility and compiled into an aggregated list (Supplementary
Dataset 19; sheet = ”ALL_DAR”). DMR were ﬂanked by a 1 kb window
and intersected with cell-speciﬁc DAR and GR CUT&RUN binding sites
using GenomicRanges in R.

Partitioned heritability of ATAC peaks
Cell-speciﬁc ATAC peaks and cell-speciﬁc DAR in diabetes were identiﬁed with the Seurat FindMarkers function, sorted by p-value, and
ﬁltered for peaks with an average log-fold-change greater than zero. All
peaks that met the adjusted p-value threshold were used to generate a
cell-speciﬁc bed ﬁle. In the event a cell type did not have at least 2000
peaks that met the adjusted p-value threshold, the top 2000 peaks
with the lowest p-value were used to create the bed ﬁle. If a cell type did
not have 2000 cell-speciﬁc peaks, all available peaks were used to
create the bed ﬁle. For the allele-speciﬁc analysis, bed ﬁles were generated using peaks that met the adjusted binomial threshold for allelic
bias of reference vs. alternate allele (N = 5593, padj < 0.05) or the
unadjusted p-value threshold for the base model (N = 7512, pval <
0.05), model 2 (N = 7557, pval < 0.05), and model 3 (N = 7353, pval <
0.05). These thresholds were used to keep the number of peaks in
each annotation roughly equivalent. Bed ﬁles were lifted over to hg19
to create annotations for autosomal chromosomes with a 1000 genomes phase 3 reference and the make_annot.py function in ldsc (1.0)
using a 100 kb window54. Linkage disequilibrium scores were computed from custom annotations with the ldsc.py function using default
parameters. GWAS summary statistics for eGFR, CKD, microalbuminuria, and urinary sodium excretion were downloaded from
publicly available databases and formatted for ldsc using
munge_sumstats.py51–53. Partitioned heritability for each GWAS trait
was estimated using the 1000 G phase 3 reference and ldsc cell-typespeciﬁc workﬂow with default parameters, including baseline v1.2
annotations after controlling for all kidney ATAC peaks in the dataset.
P-values were adjusted for multiple comparisons using BenjaminiHochberg and signiﬁcance was determined at padj < 0.05.
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Genotypes from snRNA-seq and snATAC-seq were combined and
phased with shapeit4.2 using the 1000 Genomes phased reference
for biallelic SNV and indels on GRCh3857. There was a mean of
1,917,939 (s.d. = 363,223) phased SNV and indels for each library,
which were used to perform variant-aware realignment with WASP
(0.3.4) using bwa (0.7.17) or STAR (2.5.1b) and ﬁltered with
bcftools (1.9)59. WASP-aligned bam ﬁles were divided into single
cell bam ﬁles by extracting proximal-tubule-speciﬁc barcodes
using the CB tag. GATK ASEReadCounter was used to generate
single cell allele-speciﬁc counts from single cell bam ﬁles using
phased heterozygous SNV (mean = 722,091, s.d. = 199,756).
Pseudo-multiomic cells were created by performing label
transfer from the aggregated snRNA-seq to snATAC-seq dataset to
generate an imputed RNA estimate for each snATAC-seq cell. One or
more gene targets for each ATAC peak were identiﬁed using the
LinkPeaks function. ATAC peaks with heterozygous SNV were ﬁltered
for an aggregate total fragment count >20, total reference allele
count >5, and total alternate allele count >5. The ratio of aggregated
reference counts to alternate counts within ATAC peaks containing
heterozygous SNV was compared with a binomial test. A generalized
linear mixed effect model with a logit link function was implemented
with the lme4 package83. In the base model, the dependent variable
was coded as the presence of an alternate allele within an ATAC peak
and the continuous predictor variable was the imputed RNA estimate
normalized to an interval from 0 to 100. A mixed effect per sample
was added to control for pseudo-replication bias. In model 2, an
additional ﬁxed effect for diabetes was added. In model 3, additional
ﬁxed effects for diabetes and an interaction term between diabetes
and imputed RNA expression were added. The signiﬁcance of each
peak-gene combination was evaluated using a Wald test obtained
from the glmer function. In the supplementary materials, all ﬁxedeffect coefﬁcient estimates for each peak-gene combination are
included with 95% conﬁdence intervals, Wald p-values, and standard
deviation estimates of random effects (Supplementary Dataset 20).
Peak-gene combinations meeting the nominal p-value threshold for
expression (p < 0.05) were annotated with ChIPseeker and the corresponding effect size in log-odds is visualized in relation to the
nearest TSS. These same peaks were also used to create annotations
and calculate linkage disequilibrium scores with ldsc for partitioned
heritability of eGFR as previously described.

Reporting summary
Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Allele-speciﬁc modeling with SALSA
Coordinate-sorted bam ﬁles generated by cellranger (snRNA-seq)
or cellranger-atac (snATAC-seq) were genotyped with SALSA using
GATK (4.2.0.0) best practices for germline short variant
discovery57. For snRNA-seq, reads containing Ns in their cigar
string (e.g. spanning splice junctions in snRNA-seq data) were split
using SplitNCigarReads. For snRNA-seq and snATAC-seq, base
recalibration was performed with BaseRecalibrator using hg38
GATK bundle resources, including dbsnp (v138), 1000 G phase I
indels, 1000 G phase I high-conﬁdence SNV, and Mills and 1000 G
gold standard indels. Recalibration was applied with ApplyBQSR to
create analysis-ready bam ﬁles. Variants were identiﬁed from
analysis-ready bam ﬁles with HaplotypeCaller and genotypes were
called from GVCFs using GenotypeGVCFs with default parameters.
snRNA-seq variants were hard-ﬁltered by Fisher strand bias (FS >
30), quality by depth score (QD < 2), cluster size3, and clusterwindow size (35 bp). snATAC-seq were ﬁltered using CNNScoreVariants followed by FilterVariantTranches (--snp-tranche 99.95
indel-tranche 99.4). snRNA-seq libraries had a mean total of 98,255
(s.d. = 64,847) SNVs and indels and snATAC-seq libraries had a
mean total of 2,283,904 (s.d. = 534,165) SNVs and indels.
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Data availability
All of the data for this manuscript have been made publicly available.
Raw sequencing data for snATAC-seq (N = 1 control, N = 7 DKD) and
snRNA-seq (N = 1 control, N = 2 DKD) is deposited in GEO under
accession number “GSE195460”. Previously published raw sequencing
data for snRNA-seq (N = 5 control, N = 3 DKD) and snATAC-seq (N = 5
control) are available in “GSE151302” and “GSE131882”. Processed
count matrices for all snRNA-seq (N = 11) and snATAC-seq (N = 13)
libraries used in this study are also provided in “GSE195460”.
Sequencing data for CUT&RUN from bulk kidney cortex and primary
RPTEC are deposited under accession number “GSE195443”. Sequencing data for Omni-ATAC from hTERT-RPTEC and primary RPTEC are
also deposited under accession number “GSE195443”. Gene expression
and chromatin accessibility for each cell type can be viewed on our
interactive website; “Kidney Interactive Transcriptomics [http://
humphreyslab.com/SingleCell]” (dataset: Wilson and Muto et al). All
other relevant data supporting the key ﬁndings of this study are
available within the article and its Supplementary Information ﬁles or
from the corresponding author upon reasonable request. Source data
are provided with this paper.
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Code availability
SALSA is available on GitHub (https://github.com/p4rkerw/SALSA)84.
All of the analysis code used to generate data in this manuscript is
available on GitHub (https://github.com/p4rkerw/Wilson_Muto_
NComm_2022)85.
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